Ravirajsinh Navalsinh Jadeja

This study shows that loss of FXR signaling in mice promotes choroidal neovascularization, fibrosis, and vascular leakage, suggesting FXR as a therapeutic target for nAMD.

This study shows that activating CYP46A1 reduces pathological neovascularization and improves retinal health in a mouse model of retinopathy of prematurity.

This study shows that sodium butyrate protects against retinal neovascularization in preclinical ROP models by reducing vascular, neuronal, and microglial pathology.